A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Does the January share price for Biotage AB (publ) ( STO:BIOT ) reflect what it's really worth? Today, we will estimate...
Has the Swedish Life Sciences Industry valuation changed over the past few years?
|Mon, 24 Jan 2022||kr66.8b||kr10.8b||kr786.3m||44.8x|
|Wed, 22 Dec 2021||kr82.0b||kr10.8b||kr786.3m||54.9x|
|Fri, 19 Nov 2021||kr89.2b||kr10.8b||kr788.5m||55.6x|
|Sun, 17 Oct 2021||kr93.3b||kr9.9b||kr853.6m||54.6x|
|Tue, 14 Sep 2021||kr101.3b||kr9.9b||kr853.6m||58.6x|
|Thu, 12 Aug 2021||kr90.9b||kr9.9b||kr853.6m||47.9x|
|Mon, 07 Jun 2021||kr74.6b||kr8.5b||kr852.0m||46.2x|
|Sun, 28 Feb 2021||kr55.1b||kr7.7b||kr693.0m||51.6x|
|Wed, 02 Dec 2020||kr39.8b||kr6.7b||kr455.0m||42.2x|
|Sat, 05 Sep 2020||kr41.2b||kr6.3b||kr389.2m||63.8x|
|Tue, 09 Jun 2020||kr30.5b||kr5.9b||kr322.2m||62.1x|
|Mon, 02 Mar 2020||kr24.6b||kr5.6b||kr326.8m||52.7x|
|Thu, 05 Dec 2019||kr22.6b||kr5.2b||kr342.9m||50.6x|
|Sun, 08 Sep 2019||kr20.4b||kr4.9b||kr317.5m||59.5x|
|Sat, 01 Jun 2019||kr19.4b||kr4.6b||kr299.9m||50x|
|Tue, 05 Mar 2019||kr18.9b||kr4.3b||kr274.8m||47.9x|
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 51.9x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Life Sciences industry have grown 42% per year over the last three years, and revenues for these companies have grown 37% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the Swedish Life Sciences industry?
|Clinical Research and Equipment||-3.51%|
Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry even though it's trading below its 3-year average PE ratio of 51.9x. However analysts are expecting annual earnings growth of 67%, which is lower than the prior year's growth of 78% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 67% over the next 5 years. This is roughly in line with its past earnings growth rate.
Which companies have driven the market over the last 7 days?
|BICO BICO Group||kr222.40||5.9%|
AlphaHelix Molecular Diagnostics
Genovis AB (publ.)